Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page footer revision label was updated from v3.6.0 to v3.6.2, indicating a newer release of the site software. This update reflects an underlying deployment refresh rather than changes to user-facing content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe sponsor’s name and affiliated institution are now listed as separate items to improve attribution clarity, and new navigation/help links (How to Read a Study Record, Common Questions, How to Join a Study) along with a revised label for Intervention/Treatment and an updated revision stamp were added.SummaryDifference1%

- Check23 days agoChange DetectedThe page footer revision label was updated to v3.5.5, replacing the previous v3.5.4 and indicating a minor site/template update.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label on the page updated to v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page template or accompanying content.SummaryDifference0.1%

- Check66 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version indicator is reflected at the bottom of the page.SummaryDifference0.1%

- Check73 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.